Article
Risk of second primary malignancies following radioactive iodine therapy in thyroid cancer: A meta-analysis of 1,189,992 patients
2025-10-21
Abstract excerpt
While the prognosis of thyroid cancer (TC) was generally excellent, there was a long-term concern regarding the risk of subsequent second primary malignancies (SPM) following radioactive iodine (RAI). This study aimed to comprehensively estimate the pooled risk of SPM occurrence following RAI therapy. The study searched the literature across three databases (PubMed, Scopus, and ScienceDirect), and was followed by...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 702e4ecc-b3e9-576c-b799-2df3cc852dc3
- DOI
- 10.12688/f1000research.172050.1